Regeneron Pharmaceuticals | REGN - Interest Income

Stock Price
759.19
Daily Change
4.17 0.55%
Monthly
-0.53%
Yearly
8.91%
Q1 Forecast
718.61

Regeneron Pharmaceuticals reported $175.1M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 62M 11M Jun/2025
Agios Pharmaceuticals USD 14.51M 1.57M Jun/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Astellas Pharma JPY 4.12B 2.94B Mar/2024
AstraZeneca USD 68M 16M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Eli Lilly USD 40M 8.3M Jun/2025
Gilead Sciences USD 73M 21M Jun/2025
GlaxoSmithKline GBP 50M 4M Jun/2025
Incyte USD 25.14M 2.21M Jun/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
J&J USD 2.12 0.17 Sep/2025
Kyowa Hakko Kirin JPY 2.54B 1.52B Jun/2024
Merck USD 96M 27M Sep/2025
Moderna USD 81M 9M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 114M 38M Sep/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025
United Therapeutics USD 51.3M 200K Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025